Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Boehringer Ingelheim
Mallinckrodt
Dow
Express Scripts

Last Updated: May 28, 2022

GVOKE HYPOPEN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

When do Gvoke Hypopen patents expire, and when can generic versions of Gvoke Hypopen launch?

Gvoke Hypopen is a drug marketed by Xeris and is included in one NDA. There is one patent protecting this drug.

This drug has eighteen patent family members in thirteen countries.

The generic ingredient in GVOKE HYPOPEN is glucagon. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the glucagon profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Gvoke Hypopen

A generic version of GVOKE HYPOPEN was approved as glucagon by LILLY on September 11th, 1998.

  Sign up for a Free Trial

US Patents and Regulatory Information for GVOKE HYPOPEN

GVOKE HYPOPEN is protected by one US patents and one FDA Regulatory Exclusivity.

Patents protecting GVOKE HYPOPEN

Methods for producing stable therapeutic formulations in aprotic polar solvents
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF SEVERE HYPOGLYCEMIA

FDA Regulatory Exclusivity protecting GVOKE HYPOPEN

NEW PRODUCT
Exclusivity Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xeris GVOKE HYPOPEN glucagon SOLUTION;SUBCUTANEOUS 212097-003 Sep 10, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Xeris GVOKE HYPOPEN glucagon SOLUTION;SUBCUTANEOUS 212097-004 Sep 10, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Xeris GVOKE HYPOPEN glucagon SOLUTION;SUBCUTANEOUS 212097-003 Sep 10, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Xeris GVOKE HYPOPEN glucagon SOLUTION;SUBCUTANEOUS 212097-004 Sep 10, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for GVOKE HYPOPEN

See the table below for patents covering GVOKE HYPOPEN around the world.

Country Patent Number Title Estimated Expiration
Japan 6835831 See Plans and Pricing
World Intellectual Property Organization (WIPO) 2016201248 See Plans and Pricing
European Patent Office 3307295 UTILISATION DE GLUCAGON À FAIBLE DOSE (USE OF LOW DOSE GLUCAGON) See Plans and Pricing
World Intellectual Property Organization (WIPO) 2016196976 See Plans and Pricing
Israel 258298 שיטות לייצור תכשירי גלוקגון יציבים בסולבנטים פולרים אפרוטים (Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents) See Plans and Pricing
World Intellectual Property Organization (WIPO) 2017053922 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Moodys
McKesson
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.